SPOTLIGHT -
Sirj Goswami, PhD, CEO, co-founder of InsightRX
Understanding Project Optimus
Why oncology needs dosing redesign.
Understanding FDA’s Perspective on Precision Dosing
Continued embrace of precision dosing will reduce costs and optimize clinical outcomes.
